KYMR
Price
$43.30
Change
+$2.61 (+6.41%)
Updated
Sep 3 closing price
Capitalization
3.1B
56 days until earnings call
RGNX
Price
$9.87
Change
+$0.75 (+8.22%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
498.58M
62 days until earnings call
Interact to see
Advertisement

KYMR vs RGNX

Header iconKYMR vs RGNX Comparison
Open Charts KYMR vs RGNXBanner chart's image
Kymera Therapeutics
Price$43.30
Change+$2.61 (+6.41%)
Volume$789.34K
Capitalization3.1B
REGENXBIO
Price$9.87
Change+$0.75 (+8.22%)
Volume$50.53K
Capitalization498.58M
KYMR vs RGNX Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. RGNX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (KYMR: $43.31 vs. RGNX: $9.87)
Brand notoriety: KYMR and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 124% vs. RGNX: 95%
Market capitalization -- KYMR: $3.1B vs. RGNX: $498.58M
KYMR [@Biotechnology] is valued at $3.1B. RGNX’s [@Biotechnology] market capitalization is $498.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while RGNX’s TA Score has 7 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • RGNX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +2.48% price change this week, while RGNX (@Biotechnology) price change was +11.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.26%. For the same industry, the average monthly price growth was +15.05%, and the average quarterly price growth was +29.52%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.1B) has a higher market cap than RGNX($499M). RGNX YTD gains are higher at: 27.684 vs. KYMR (7.656). RGNX has higher annual earnings (EBITDA): -129.93M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. RGNX (323M). RGNX has less debt than KYMR: RGNX (77.7M) vs KYMR (85.7M). RGNX has higher revenues than KYMR: RGNX (156M) vs KYMR (44.7M).
KYMRRGNXKYMR / RGNX
Capitalization3.1B499M621%
EBITDA-267.03M-129.93M206%
Gain YTD7.65627.68428%
P/E RatioN/AN/A-
Revenue44.7M156M29%
Total Cash665M323M206%
Total Debt85.7M77.7M110%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRRGNX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFMAX36.52N/A
N/A
Davidson Multi-Cap Equity A
KAUCX4.14N/A
N/A
Federated Hermes Kaufmann C
SILLX28.12N/A
N/A
Franklin Global Equity C
TFGRX46.16N/A
N/A
Touchstone Mid Cap Growth R6
LAFGX16.13N/A
N/A
Lord Abbett International Growth F